TCM Biotech International Corp.

Research TCM Biotech International Corp. (4169.TW) on Bullrun: market cap TWD 9.62B, dividend yield 0.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 9.62B; dividend yield is 0.3%.

Peer valuation comparison

Latest dividend yield is 0.27% versus a Healthcare sector median of 2.4% (88.8% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 9.62Bn/a0.2%0.32

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.32 TWD, yield 0.3%.

About TCM Biotech International Corp.

TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is TCM Biotech International Corp.'s market cap?

TCM Biotech International Corp.'s market capitalization is TWD 9.62B.

Does TCM Biotech International Corp. pay a dividend?

TCM Biotech International Corp. has a dividend yield of 0.3%.

What does TCM Biotech International Corp. do?

TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant/mucolytic agent, anticancer drug, antihypertensive drug, and antidiabetic.